America's Essential Hospitals called on CMS to provide an adequate annual payment update to cover the effects of inflation and rising workforce costs.

In the Sept. 14 letter to House and Senate leaders, members of America’s Essential Hospitals warned of the “far-reaching effects” of scheduled deep cuts to Medicaid disproportionate share hospital funding and said the cuts would “undermine America’s health care safety net.”

House and Senate lawmakers are advancing proposals requiring site-neutral payments for hospital outpatient services. Now is the best time to tell your congressional delegations how these policies will affect your hospital.

We urge Congress to protect access to care for the most vulnerable communities and not enact further hospital site-neutral payment proposals, which would disproportionately and negatively impact essential hospitals.

In a recent letter to House leaders, America's Essential Hospitals voiced its support of a legislative proposal that would avert $16 billion in cuts to Medicaid disproportionate share hospital funding but cautioned against other onerous policies, including for site-neutral payment.

Political posturing on appropriations has made a government shutdown next month increasingly likely. Congress also faces a Sept. 30 deadline for other key issues, including stopping an $8 billion cut to Medicaid DSH funding.

While lawmakers are home during August recess, we encourage you to invite your congressional delegation to visit your hospital and urge them to support essential hospital priorities.

In its response to a bipartisan group of senators, America's Essential Hospitals urges lawmakers to resist drug industry attacks on the 340B Drug Pricing Program and to protect the program's benefits to essential hospitals and marginalized patients.

The rule revises site-neutral payment policies, updates price transparency requirements, and changes outpatient quality reporting, among other provisions.

The House Committee on Energy and Commerce approved a measure to eliminate $16 billion of cuts to Medicaid disproportionate share hospital funding as part of a package that also includes measures for pricing transparency and site-neutral payments.

House panels last week heard testimony on a variety of issues important to essential hospitals, including looming cuts to Medicaid disproportionate share hospital funding, workforce shortages and training, and the 340B Drug Pricing Program.

The final rule reverses Medicare Part B drug payment cuts to hospitals in the 340B Drug Pricing Program, continues site-neutral payment policies, and revises the inpatient-only list, among other proposed changes.

A proposed rule for Medicare’s Outpatient Prospective Payment System for calendar year 2023 would reverse Medicare Part B drug payment cuts to hospitals in the 340B Drug Pricing Program, continue site-neutral payment policies, and revise the inpatient-only list, among other proposed changes.

The commission's June report to Congress includes illustrative policies about defining and supporting Medicare safety net providers and aligning payments across outpatient settings, among other topics of interest to essential hospitals.

The Medicare Outpatient Prospective Payment System final rule for calendar year 2022 continues cuts to hospitals in the 340B Drug Pricing Program and pauses elimination of the inpatient-only list. The rule also includes provisions on price transparency, rural emergency hospitals, and health equity.

Proposed rules for Medicare’s Outpatient Prospective Payment System and Physician Fee Schedule would continue Medicare Part B cuts, continue site-neutral policies, and halt the phase-out of the inpatient-only list. Both rules also contain an information request on closing the health equity gap.

The OPPS proposed rule would continue cuts to hospitals in the 340B Drug Pricing Program and off-campus provider-based departments, pause the elimination of the inpatient-only list, and increase penalties for failing to report standard charges.

America's Essential Hospitals sent a letter to President Joe Biden and his administration detailing key priorities for essential hospitals, including issues related to structural racism, COVID-19, Medicaid, the 340B Drug Pricing Program, site-neutral payment policies, immigration, and other topics.

Final rules for Medicare’s Outpatient Prospective Payment System and Physician Fee Schedule for calendar year 2021 continue Medicare Part B drug payment cuts to hospitals in the 340B Drug Pricing Program and site-neutral payment policies.

The Medicare Outpatient Prospective Payment System final rule for calendar year 2021 continues cuts to hospitals in the 340B Drug Pricing Program and off-campus provider-based departments, and updates the overall hospital star ratings methodology.